Bms is Bristol Myers Squibb, a corporate strategic investor and biopharmaceutical company based in Princeton, New Jersey. It deploys capital through partnerships and business development rather than a traditional venture fund model, with relevance for founders in biotechnology, life sciences, oncology and pharmaceuticals, including therapeutics and drug-development platforms aligned with oncology, hematology, neuroscience, immunology and cardiovascular medicine.